Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol

Primary treatment of carcinoma of the oro-/hypopharynx or larynx may consist of combined platinum-containing chemoradiotherapy. In order to improve clinical outcome (i.e. local control/overall survival), combined therapy is intensified by the addition of the EGFR inhibitor cetuximab (Erbitux®). Radi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Habl, Gregor (VerfasserIn) , Jensen, Alexandra (VerfasserIn) , Potthoff, Karin (VerfasserIn) , Uhl, Matthias (VerfasserIn) , Hof, Holger (VerfasserIn) , Hajda, Jacek (VerfasserIn) , Simon, Christian (VerfasserIn) , Debus, Jürgen (VerfasserIn) , Krempien, Robert (VerfasserIn) , Münter, Marc (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 26 November 2010
In: BMC cancer
Year: 2010, Jahrgang: 10, Pages: 1-8
ISSN:1471-2407
DOI:10.1186/1471-2407-10-651
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-2407-10-651
Volltext
Verfasserangaben:Gregor Habl, Alexandra D. Jensen, Karin Potthoff, Matthias Uhl, Holger Hof, Jacek Hajda, Christian Simon, Jürgen Debus, Robert Krempien, Marc W. Münter
Beschreibung
Zusammenfassung:Primary treatment of carcinoma of the oro-/hypopharynx or larynx may consist of combined platinum-containing chemoradiotherapy. In order to improve clinical outcome (i.e. local control/overall survival), combined therapy is intensified by the addition of the EGFR inhibitor cetuximab (Erbitux®). Radiation therapy (RT) is carried out as intensity-modulated RT (IMRT) to avoid higher grade acute and late toxicity by sparing of surrounding normal tissues.
Beschreibung:Gesehen am 09.06.2023
Beschreibung:Online Resource
ISSN:1471-2407
DOI:10.1186/1471-2407-10-651